{
  "docId": "019de072-13bd-74ea-b396-bd93a39bdc94",
  "docSlug": "96003a7ba08cc5f25ee9ab531ee7db70",
  "documentTitle": "Alkermes | Results Presentation Deck | 18 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 18,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-13bd-74ea-b396-bd93a39bdc94/5",
  "deckHref": "/decks/019de072-13bd-74ea-b396-bd93a39bdc94",
  "deckJsonHref": "/decks/019de072-13bd-74ea-b396-bd93a39bdc94.json",
  "deckAnchorHref": "/decks/019de072-13bd-74ea-b396-bd93a39bdc94#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.58
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc6f3a17-ea58-4972-99d2-c63b9e90996d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "Commercial Execution: LYBALVI approved/launched, ARISTADA growth, VIVITROL strategy.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32f04e81-0107-4f27-a7bd-d9cbd53ef93f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.05,
        "y": 0.78
      },
      "kind": "list",
      "text": "Corporate Responsibility: Patient advocacy, D&I, sustainability.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34738238-f604-4b94-afb8-ddafabddd515",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.35,
        "y": 0.3
      },
      "kind": "list",
      "text": "Development Pipeline: nemvaleukin alfa studies, ALKS 1140 phase 1, ALKS 2680 IND-enabling.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8adf99b6-93e1-4329-9494-0708889f323f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.78
      },
      "kind": "list",
      "text": "Governance: Board refreshment, independent directors, declassification.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3ae3a5f-db89-44f8-8b6a-9c6da477d1d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.65,
        "y": 0.3
      },
      "kind": "list",
      "text": "Profitability: Disciplined capital allocation, cost structure optimization, commercial restructuring.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee1decf4-e5ba-4712-9f22-f6d38fc5dc93",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "Patient-focused ethos and strong commitment to corporate responsibility and governance",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9dfc5fe8-5bfa-438e-97b7-3bfeea97c8e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "title",
      "text": "2021 Key Achievements Advanced Core Business Objectives",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7591729-723f-4d0f-920c-fb584eb377ac",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "aa1e8bc0-b947-4770-a74d-aed587b7d93e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The key messages and takeaways slides provide an overview of Alkermes' strategic priorities and achievements",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}